Remdesivir GS-5734 CAS 1809249-37-3 COVID-19 API Umgangatho oPhezulu
Ubonelelo ngezoRhwebo loMvelisi i-Remdesivir kunye nabaPhakathi abaNxulumeneyo nabanoMgangatho oPhezulu
I-Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
I-Trimethylsilyl Cyanide CAS 7677-24-9
I-4-Nitrophenol CAS 100-02-7
I-2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
I-Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
I-Remdesivir N-2 ePhakathi CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
I-Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Igama leMchiza | I-Remdesivir |
Izithethantonye | GS-5734;2-ethylbutyl ((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano -3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate |
Inombolo yeCAS | 1809249-37-3 |
Inombolo yeCAT | I-RF-API96 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | I-C27H35N6O8P |
Ubunzima beMolekyuli | 602.58 |
Ukuxinana | 1.47±0.1 g/cm3 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oqinileyo oMhlophe ukuya koMhlophe |
Isazisi A | IR: I-infrared absorption spectrum yemveliso kufuneka ihambelane naleyo yereferensi yezinto. |
Isazisi B | Ixesha logcino lwe-HPLC liyafana nereferensi yento |
Ukujikeleziswa okuthe ngqo | -19.0 ° ~ -22.0 ° |
Ukunyibilika | I-Solun kwi-Methanol, iNyibilika kancinane kwi-Ethanol, iNyibilika kancinane kwi-acetonitrile, ayiNyibiliki ngokuthe ngqo emanzini. |
Izinto ezinxulumeneyo | |
Nakuphi na Ukungacoceki komntu | ≤0.10% |
Ukungcola ngokupheleleyo | ≤1.0% |
I-RD-3.1 | ≤0.10% |
RD-C | ≤0.10% |
RD-D | ≤0.10% |
RD-E | ≤0.10% |
RP-Isomer | ≤0.10% |
Nitrophenol | ≤0.10% |
Izinyibilikisi ezishiyekileyo | |
I-Methanol Dichloride | ≤6000ppm |
I-acetone | ≤5000ppm |
Isopropyl Utywala | ≤5000ppm |
Acetonitrile | ≤410ppm |
Dichloromethane | ≤600ppm |
I-Methyl tert Butyl Ether | ≤5000ppm |
I-Ethyl Acetate | ≤5000ppm |
Tetrahydrofuran | ≤720ppm |
n-Heptane | ≤5000ppm |
Isivavanyi | 98.0% ~ 102.0% (Ibalwe kwisiseko somisiwe) |
Ubalo lweAerobic iyonke | |
Intsholongwane yeAerobic | ≤100cfu/g |
Igwele kunye noMngundo | ≤10cfu/g |
E. Ikhoyili | Ibi |
I-Endotoxin yebhaktiriya | ≤1.0EU |
Iintsimbi ezinzima | ≤20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API, COVID-19 |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Remdesivir (i-CAS 1809249-37-3), ethengiswa phantsi kwegama le-brand Veklury, liyeza elibanzi lokulwa nentsholongwane eliphuhliswe yinkampani ye-biopharmaceutical yaseGilead Sciences.Isetyenziswa ngesitofu emithanjeni.Ngexesha lobhubhani we-COVID-19, i-remdesivir yamkelwa okanye yagunyaziswa ukuba isetyenziswe ngokungxamisekileyo ukunyanga i-COVID-19 kumazwe amalunga nama-50.Izikhokelo ezihlaziyiweyo ezivela kuMbutho wezeMpilo weHlabathi ngoNovemba ka-2020 zibandakanya isindululo esinemiqathango ngokuchasene nokusetyenziswa kwe-Remdesivir kunyango lwe-COVID-19.I-Remdesivir yaqala yaphuhliswa ukunyanga i-hepatitis C, kwaye emva koko yaphandwa ngenxa yesifo sentsholongwane ye-Ebola kunye nosulelo lwentsholongwane yaseMarburg ngaphambi kokuba ifundwe njengonyango lwasemva kokosulelwa yi-COVID-19.Impembelelo yecala eliqhelekileyo kumavolontiya aphilileyo iphakamisa amanqanaba egazi le-enzyme yesibindi (uphawu lweengxaki zesibindi).Esona siphumo sixhaphakileyo kubantu abane-COVID-19 sisicaphucaphu.Iziphumo ebezingalindelekanga zinokubandakanya ukudumba kwesibindi kunye nempendulo enxulumene nokutofa kunye nesicaphucaphu, uxinzelelo lwegazi oluphantsi, kunye nokubila.I-Remdesivir yiprodrug enenjongo yokuvumela ukuhanjiswa kwe-intracellular ye-GS-441524 monophosphate kunye ne-biotransformation elandelayo kwi-GS-441524 triphosphate, i-ribonucleotide analogue inhibitor ye-viral RNA polymerase.